DISCRETE LOCALIZATION OF DIFFERENT DNA TOPOISOMERASES IN HELA AND K562 CELL-NUCLEI AND SUBNUCLEAR FRACTIONS

被引:65
作者
ZINI, N
SANTI, S
OGNIBENE, A
BAVELLONI, A
NERI, LM
VALMORI, A
MARIANI, E
NEGRI, C
ASTALDIRICOTTI, GCB
MARALDI, NM
机构
[1] IOR,CNR,IST CITOMORFOL NORMALE & PATOL,I-40136 BOLOGNA,ITALY
[2] IOR,BIOL CELLULARE & MICROSCOPIA ELETTRON LAB,BOLOGNA,ITALY
[3] IOR,IMMUNOL & GENET LAB,BOLOGNA,ITALY
[4] CNR,IST GENET BIOCHIM & EVOLUZIONIST,I-27100 PAVIA,ITALY
[5] UNIV FERRARA,IST ANAT UMANA,FERRARA,ITALY
关键词
D O I
10.1006/excr.1994.1046
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Monoclonal antibodies raised against DNA topoisomerase I and against topoisomerase II ,α and β isoforms, which have been previously demonstrated to be highly specific and capable of detecting cell cycle-related variations of the topoisomerase II isoforms (Negri et al., 1992, Exp. Cell Res. 200, 452-459), have been utilized for a fine subcellular localization. Immunocytochemistry by confocal and electron microscopy have been used for a topological and quantitative evaluation of the fine distribution of the different topoisomerases in HeLa and K562 cells. Topoisomerase I and topoisomerase II α are present both in the nucleoplasm and in the nucleolus, though at different relative ratios, while topoisomerase II β is exclusively present at the nucleolar level. This is further confirmed by immunoblotting and immunocytochemical quantitative evaluations performed on purified nuclear matrix fractions obtained from K562 cells. In fact, the amount of topoisomerase I and topoisomerase II α present in the whole cell nuclei is partly lost in isolated nuclei but, while topoisomerase I is further significantly reduced in nuclear matrix preparations, the topoisomerase II α content is only slightly decreased. On the other hand, the great majority of topoisomerase II β is retained in the nuclear matrix and can be detected exclusively in association with the nucleolar remnant. These results are consistent with specific functional roles hypothesized for the different topoisomerase types. © 1994 Academic Press, Inc.
引用
收藏
页码:336 / 348
页数:13
相关论文
共 50 条
[1]   CHROMOSOME ASSEMBLY INVITRO - TOPOISOMERASE-II IS REQUIRED FOR CONDENSATION [J].
ADACHI, Y ;
LUKE, M ;
LAEMMLI, UK .
CELL, 1991, 64 (01) :137-148
[2]   INSITU LOCALIZATION OF DNA TOPOISOMERASE-II, A MAJOR POLYPEPTIDE COMPONENT OF THE DROSOPHILA NUCLEAR MATRIX-FRACTION [J].
BERRIOS, M ;
OSHEROFF, N ;
FISHER, PA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (12) :4142-4146
[3]   PROTEIN - DNA INTERACTIONS AT CHROMOSOMAL LOOP ATTACHMENT SITES [J].
BLASQUEZ, VC ;
SPERRY, AO ;
COCKERILL, PN ;
GARRARD, WT .
GENOME, 1989, 31 (02) :503-509
[4]  
BODLEY AL, 1986, NATL CANCER I MONOGR, V4, P31
[5]   ASSOCIATION OF CROSSOVER POINTS WITH TOPOISOMERASE-I CLEAVAGE SITES - A MODEL FOR NONHOMOLOGOUS RECOMBINATION [J].
BULLOCK, P ;
CHAMPOUX, JJ ;
BOTCHAN, M .
SCIENCE, 1985, 230 (4728) :954-958
[6]   CHARACTERIZATION AND IMMUNOLOGICAL IDENTIFICATION OF CDNA CLONES ENCODING 2 HUMAN DNA TOPOISOMERASE-II ISOZYMES [J].
CHUNG, TDY ;
DRAKE, FH ;
TAN, KB ;
PER, SR ;
CROOKE, ST ;
MIRABELLI, CK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (23) :9431-9435
[7]  
DRAKE FH, 1987, J BIOL CHEM, V262, P16739
[8]   BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF P170 AND P180 FORMS OF TOPOISOMERASE-II [J].
DRAKE, FH ;
HOFMANN, GA ;
BARTUS, HF ;
MATTERN, MR ;
CROOKE, ST ;
MIRABELLI, CK .
BIOCHEMISTRY, 1989, 28 (20) :8154-8160
[9]   TOPOISOMERASE-II IS A STRUCTURAL COMPONENT OF MITOTIC CHROMOSOME SCAFFOLDS [J].
EARNSHAW, WC ;
HALLIGAN, B ;
COOKE, CA ;
HECK, MMS ;
LIU, LF .
JOURNAL OF CELL BIOLOGY, 1985, 100 (05) :1706-1715
[10]   LOCALIZATION OF TOPOISOMERASE-II IN MITOTIC CHROMOSOMES [J].
EARNSHAW, WC ;
HECK, MMS .
JOURNAL OF CELL BIOLOGY, 1985, 100 (05) :1716-1725